Medigas New Oral Drops contain a combination of Dicyclomine (10mg) and Simethicone (40mg) per dose, formulated to provide effective relief from gastrointestinal discomfort associated with functional bowel disorders. Dicyclomine is an anticholinergic agent that acts by inhibiting the muscarinic action of acetylcholine on smooth muscles of the gastrointestinal tract, thereby reducing intestinal motility and spasms. Simethicone is an anti-foaming agent that decreases surface tension of gas bubbles, facilitating their coalescence and expulsion, which helps alleviate bloating and flatulence. This synergistic combination makes Medigas New Oral Drops suitable for patients experiencing abdominal cramps, spasms, and excessive gas accumulation. The oral drop formulation allows for easy administration and rapid onset of action. Medigas New Oral Drops should be used as directed by a healthcare professional, with caution advised in patients with hypersensitivity to any component, obstructive gastrointestinal conditions, or severe ulcerative colitis. Common side effects may include dry mouth, dizziness, or mild gastrointestinal disturbances. This product is intended for symptomatic relief and should not replace medical evaluation in cases of persistent or severe abdominal pain. Always consult a physician before use, especially in pregnant or lactating women.